AstraZeneca contributes to global rescue effort for Haiti

Wednesday, 13 January 2010

AstraZeneca is contributing to the global rescue effort in the wake of Haiti’s devastating earthquake. We have donated antibiotic and respiratory medicines (Meronem, Pulmicort and Rhinocort) through US charity AmeriCares and through Health Partners International in Canada, cardiovascular, gastrointestinal and respiratory (Tenormin, Losec, Nexium, Bricanyl, Pulmicort Turbuhaler) medicines.

In addition to our initial donation of $160,000, we have now donated a further $340,000 to the British Red Cross Emergency Appeal. We have also committed an additional $500,000 to support a longer-term disaster recovery programme that will give the people of Haiti the help they need to re-build their lives and their communities. We are currently working with AstraZeneca colleagues in the region to identify appropriate projects and partners.

LabTalk is AstraZeneca’s science-focused blog where you can hear from scientists, researchers and academics discussing novel ideas, research and innovation.

The_PARP_THM 19 December 2014

The PARP inhibitor paradigm: a collaborative approach to cancer drug discovery

Targeting_escape_THM 10 December 2014

Targeting escape pathways to further personalise breast cancer treatment

Accelerating_THM 8 December 2014

Accelerating drug discovery for brain disorders – a partnership model